John Gandolfo - Oct 4, 2023 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Julio C. Esquivel, as Attorney-in-Fact for John Gandolfo
Stock symbol
OGEN
Transactions as of
Oct 4, 2023
Transactions value $
$0
Form type
4
Date filed
10/6/2023, 04:33 PM
Previous filing
Aug 8, 2023
Next filing
Jan 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Non-Employee Director Option (Right to Buy) Award $0 +5.1K $0.00 5.1K Oct 4, 2023 Common Stock 5.1K $2.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately.